Trellis Bioscience Lands $11,450,000 New Financing

  • Feed Type
  • Date
    9/30/2009
  • Company Name
    Trellis Bioscience
  • Mailing Address
    2-B Corporate Drive South San Francisco, CA 94080
  • Company Description
    Trellis Bioscience, Inc. has developed a breakthrough technology platform for discovery and selection of very rare cells that produce ideal proteins such as antibodies, selected for specificity, selectivity, affinity, secretion rate and other desired characteristics. The company’s proprietary CellSpot™ platform is at the convergence of nanotechnology, software, digital microscopy and biology and allows for a parallel evaluation of millions of cells simultaneously in a way that enables the valuable one in one million cells to be reliably identified and re-covered.
  • Website
    http://www.trellisbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,450,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy